MED MEDIFAST INC Common Stock
NYSE · Consumer products · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 3, 2026MED Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
MED Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
About MEDIFAST INC Common Stock Company overview from Wikipedia
Medifast, Inc. (NYSE: MED) is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.
Subsidiaries
The company owns five subsidiaries:
Jason Pharmaceuticals, Inc.
Take Shape for Life, Inc. (TSFL) (renamed Optavia from July 2017)
Jason Enterprises, Inc.
Jason Properties, LLC
Seven Crondall, LLC
History
William Vitale, a medical doctor, founded Medifast in 1980. He sold his products directly to other doctors, who in turn prescribed them to their patients alongside behavioural counselling techniques.
The company is publicly traded on the New York Stock Exchange (symbol: MED).
On July 17, 1995, HealthRite (predecessor of Medifast) changed its name from Vitamin Specialties Corp.
In 2000 the company pivoted to a direct-to-consumer marketing program with the help of Jason Pharmaceuticals and in 2001, the company changed its name to Medifast, Inc. In 2002, Retired Marine Colonel Bradley T. MacDonald, Chairman of the Board at the time, along with clinical specialist Dr. Wayne Scott Andersen, created Take Shape For Life as a personal Coach to the Client system and the company's “Habits of Health System.”
In October 2010, Medifast was ranked number 1 on Forbes magazine's list of "America's 100 Best Small Companies". The company was ranked 18th on the 2014 list.
Medifast was named one of Forbes's 100 Most Trustworthy Companies in America in 2016 and 2017.
In July 2017, Medifast changed the name of its subsidiary Take Shape For Life to Optavia and introduced a new line of products, Optavia Essentials, directly sold from Coaches to clients.
In October 2017, Medifast relocated its headquarters to Baltimore from Owings Mills, Maryland. The company is public with a market capitalization of $2.106 billion, as of June 2022.
In December 2023, Medifast announced a partnership with LifeMD, a provider of virtual healthcare services. Under the agreement, Medifast will use LifeMD's virtual platform to offer Medifast clients a clinically supported weight management program, including the option for prescription GLP-1 medications where clinically appropriate. In return, LifeMD will provide its patients with an independent Medifast Coach and additional lifestyle support services for weight management.
False advertising settlement
In September 2012, Medifast's subsidiary, Jason Pharmaceuticals, paid a $3.7 million USD civil penalty for false advertising. The Federal Trade Commission and United States Department of Justice said that advertisements for the "Medifast 5 & 1 Plan" low-calorie diet told consumers they could "lose up to 2-5 pounds per week", and that these weight-loss claims lacked a reasonable scientific basis, and were unsubstantiated. Under the settlement, any future claims made by the company must be backed by at least one human clinical study.
Source: Wikipedia, CC BY-SA 4.0 · View on Wikipedia ↗
10-Year Performance Revenue, net income, margins and EPS trends
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | MED | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | -5.15Y avg ≈23.6 | ≈23.6 | · | · | |
| P/S (TTM) | 0.45Y avg ≈0.7 | ≈0.7 | 0.8 | Undervalued | |
| P/B (MRQ) | 0.75Y avg ≈5.0 | ≈5.0 | 2.2 | Undervalued | |
| Price / FCF (TTM) | 32.75Y avg ≈31.6 | ≈31.6 | · | · | |
| Price / Cash Flow (TTM) | 14.95Y avg ≈12.4 | ≈12.4 | 13.9 | Pricier | |
| Price / Tangible Book | 0.65Y avg ≈5.0 | ≈5.0 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | MED | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Gross Margin (TTM) | 69.2%5Y avg ≈72.5% | ≈72.5% | 69.9% | In line | |
| Operating Margin (TTM) | -6.2%5Y avg ≈6.9% | ≈6.9% | 3.3% | Weak | |
| EBITDA Margin (TTM) | -1.8%5Y avg ≈8.5% | ≈8.5% | 4.7% | Weak | |
| Pretax Margin (TTM) | -4.4%5Y avg ≈7.4% | ≈7.4% | 3.3% | Weak | |
| Net Profit Margin (TTM) | -8.1%5Y avg ≈4.9% | ≈4.9% | 1.2% | Weak | |
| ROA (TTM) | -9.7%5Y avg ≈22.9% | ≈22.9% | 7.6% | Weak | |
| ROE (TTM) | -12.4%5Y avg ≈43.7% | ≈43.7% | 12.0% | Weak | |
| ROIC | -23.7%5Y avg ≈39.9% | ≈39.9% | 7.2% | Weak |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | MED | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 4.95Y avg ≈2.8 | ≈2.8 | 1.9 | Strong liquidity | |
| Quick Ratio | 3.95Y avg ≈1.7 | ≈1.7 | 0.4 | Strong liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | MED | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | -36.0%5Y avg ≈-8.9% | ≈-8.9% | · | · | |
| Revenue CAGR 3Y | -37.7%5Y avg ≈-19.9% | ≈-19.9% | · | · | |
| Revenue CAGR 5Y | -16.2% | · | · | · | |
| EPS YoY | -97.9%5Y avg ≈-18.7% | ≈-18.7% | · | · | |
| Net Income YoY | -97.9%5Y avg ≈-20.4% | ≈-20.4% | · | · | |
| EPS CAGR 3Y | -76.1% | · | · | · | |
| Net Income CAGR 3Y | -76.6% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | MED | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 1.45Y avg ≈3.2 | ≈3.2 | 1.0 | Top tier | |
| Inventory Turnover | 3.55Y avg ≈3.3 | ≈3.3 | 2.5 | Top tier | |
| Revenue / Employee | ≈$1.0M | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Dividends Yield, payout ratio, dividend history, 5Y CAGR
| Ex-date | Amount | Currency | Yield |
|---|---|---|---|
| Sep 18, 2023 | $1.65 | USD | ≈8.2% |
| Jun 26, 2023 | $1.65 | USD | ≈7.3% |
| Mar 27, 2023 | $1.65 | USD | ≈6.6% |
| Dec 19, 2022 | $1.64 | USD | ≈5.7% |
| Sep 19, 2022 | $1.64 | USD | ≈5.4% |
| Jun 27, 2022 | $1.64 | USD | ≈3.2% |
| Mar 28, 2022 | $1.64 | USD | ≈3.5% |
| Dec 20, 2021 | $1.42 | USD | ≈2.6% |
| Sep 20, 2021 | $1.42 | USD | ≈2.5% |
| Jun 21, 2021 | $1.42 | USD | ≈1.9% |
| Mar 29, 2021 | $1.42 | USD | ≈2.3% |
| Dec 21, 2020 | $1.13 | USD | ≈2.3% |
| Sep 21, 2020 | $1.13 | USD | ≈3.1% |
| Jun 29, 2020 | $1.13 | USD | ≈3.0% |
| Mar 30, 2020 | $1.13 | USD | ≈5.9% |
| Dec 26, 2019 | $1.13 | USD | ≈3.1% |
| Sep 26, 2019 | $0.75 | USD | ≈3.0% |
| Jun 27, 2019 | $0.75 | USD | ≈2.5% |
| Mar 28, 2019 | $0.75 | USD | ≈1.9% |
| Dec 20, 2018 | $0.75 | USD | ≈1.8% |
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 10, 2026 | $-0.28 | $-0.66 | 57.3% |
| March 31, 2026 | $-0.19 | $-0.53 | 63.8% | |
| Dec. 31, 2025 | $-1.65 | $-0.83 | -99.2% | |
| Sept. 30, 2025 | $-0.21 | $-0.39 | 46.7% | |
| June 30, 2025 | $0.22 | $-0.22 | 199.0% | |
| March 31, 2025 | $-0.11 | $-0.27 | 59.7% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $386M | $602M | $1.07B | $1.60B | $1.53B | $935M | $714M | $501M | $302M | $275M | $273M | $285M | |
| Cost of Revenue | $111M | $158M | $296M | $458M | $398M | $237M | $177M | $121M | $74M | $69M | $71M | $76M | |
| Gross Profit | $275M | $445M | $776M | $1.14B | $1.13B | $698M | $537M | $380M | $228M | $206M | $201M | $209M | |
| R&D Expense | $4M | $5M | $5M | $4M | $4M | $3M | $3M | $2M | $2M | $2M | $2M | $1M | |
| SG&A Expense | $289M | $442M | $649M | $956M | $911M | $564M | $446M | $311M | $188M | $179M | $173M | $179M | |
| Operating Income | $-14M | $3M | $126M | $185M | $216M | $134M | $91M | $69M | $40M | $27M | $29M | $30M | |
| Other Non-op | $3M | $-4M | $-95.0K | $-747.0K | $119.0K | $-140.0K | $29.0K | $179.0K | $136.0K | $-20.0K | $326.0K | $731.0K | |
| Pretax Income | $-6M | $4M | $129M | $184M | $216M | $134M | $92M | $71M | $40M | $27M | $30M | $32M | |
| Income Tax | $13M | $2M | $29M | $40M | $52M | $31M | $14M | $15M | $13M | $9M | $10M | $11M | |
| Net Income | $-19M | $2M | $99M | $144M | $164M | $103M | $78M | $56M | $28M | $18M | $20M | $13M | |
| EPS (Basic) | $-1.70 | $0.19 | $9.13 | $12.82 | $14.01 | $8.74 | $6.62 | $4.67 | $2.32 | $1.51 | $1.68 | $1.04 | |
| EPS (Diluted) | $-1.70 | $0.19 | $9.10 | $12.73 | $13.89 | $8.68 | $6.43 | $4.62 | $2.29 | $1.49 | $1.66 | $1.03 | |
| Shares (Basic) | 10,981,000 | 10,930,000 | 10,884,000 | 11,195,000 | 11,705,000 | 11,771,000 | 11,771,000 | 11,947,000 | 11,924,000 | 11,842,000 | 11,959,000 | 12,670,000 | |
| Shares (Diluted) | 10,981,000 | 10,963,000 | 10,921,000 | 11,276,000 | 11,813,000 | 11,850,000 | 12,117,000 | 12,079,000 | 12,088,000 | 11,947,000 | 12,071,000 | 12,778,000 | |
| EBITDA | $29.0K | $16M | $140M | $196M | $223M | $141M | $96M | $73M | $44M | $32M | $36M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $89M | $91M | $94M | $88M | $104M | $164M | $77M | $81M | $75M | $52M | $42M | $24M | |
| Short-term Investments | $78M | $71M | $56M | $0 | $5M | $11M | $16M | $20M | $24M | $24M | $25M | $28M | |
| Receivables | · | · | · | · | · | $584.0K | $1M | $1M | $576.0K | $1M | $2M | $2M | |
| Inventory | $20M | $42M | $55M | $119M | $180M | $53M | $49M | $39M | $19M | $18M | $13M | $16M | |
| Prepaid Expense | $9M | $10M | $11M | $16M | $16M | $6M | $6M | $5M | $4M | $4M | $3M | $3M | |
| Current Assets | $202M | $214M | $224M | $223M | $307M | $234M | $154M | $146M | $125M | $101M | $87M | $82M | |
| PP&E (Net) | $31M | $38M | $51M | $57M | $56M | $28M | $26M | $20M | $19M | $20M | $29M | $33M | |
| PP&E (Gross) | $99M | $96M | $99M | $97M | $89M | $55M | $49M | $54M | $52M | $56M | $75M | $74M | |
| Accum. Depreciation | $68M | $58M | $47M | $40M | $33M | $27M | $23M | $35M | $33M | $36M | $46M | $40M | |
| Other Non-current Assets | $8M | $10M | $15M | $12M | $6M | $3M | $353.0K | $1M | $2M | $162.0K | $205.0K | $497.0K | |
| Total Assets | $248M | $284M | $310M | $316M | $398M | $276M | $195M | $169M | $146M | $121M | $116M | $116M | |
| Accounts Payable | $38M | $56M | $86M | $135M | $163M | $108M | $76M | $60M | $37M | $24M | $23M | $22M | |
| Current Liabilities | $43M | $64M | $92M | $141M | $170M | $111M | $79M | $60M | $37M | $24M | $24M | $27M | |
| Capital Leases | $6M | $10M | $16M | $20M | $26M | $7M | $10M | · | · | · | $0 | $242.0K | |
| Deferred Tax | · | · | · | · | · | · | · | · | $208.0K | $779.0K | $4M | $5M | |
| Total Liabilities | $49M | $74M | $108M | $161M | $196M | $119M | $90M | $60M | $37M | $25M | $28M | $35M | |
| Common Stock | $11.0K | $11.0K | $11.0K | $11.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | |
| Paid-in Capital | $40M | $33M | $27M | $22M | $12M | $8M | · | $9M | $5M | $3M | $0 | $1M | |
| Retained Earnings | $158M | $177M | $175M | $140M | $190M | $154M | $169M | $131M | $104M | $93M | $89M | $79M | |
| Treasury Stock | · | · | $0 | $6M | $0 | $5M | $64M | $31M | · | · | · | $0 | |
| AOCI | $234.0K | $180.0K | $248.0K | $24.0K | $111.0K | $41.0K | $25.0K | $-173.0K | $-160.0K | $-165.0K | $-62.0K | $435.0K | |
| Stockholders' Equity | $199M | $210M | $201M | $155M | $202M | $157M | $105M | $109M | $107M | $96M | $89M | $80M | |
| Liabilities + Equity | $248M | $284M | $310M | $316M | $398M | $276M | $195M | $169M | $146M | $121M | $116M | $116M | |
| Shares Outstanding | 10,991,000 | 10,938,000 | 10,896,000 | 10,873,000 | 11,593,000 | 11,772,000 | 11,764,000 | 11,868,000 | 11,971,000 | 11,871,000 | 11,797,000 | 12,075,764 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $14M | $13M | $13M | $11M | $7M | $4M | $5M | $4M | $4M | $5M | $7M | $8M | |
| Stock-based Comp | $8M | $7M | $8M | $11M | $10M | $7M | $5M | $3M | $4M | $3M | $3M | $4M | |
| Deferred Tax | $11M | $-7M | $1M | $-924.0K | $-4M | $601.0K | $2M | $-3M | $-623.0K | $-3M | $-106.0K | $286.0K | |
| Restructuring | · | · | · | · | · | · | · | · | · | $1M | · | · | |
| Other Non-cash | $-8M | $10M | $26M | $30M | $-82M | $28M | $-4M | $155.0K | $8M | $2M | $-737.0K | · | |
| Operating Cash Flow | $7M | $24M | $148M | $195M | $95M | $145M | $84M | $61M | $43M | $25M | $29M | $26M | |
| CapEx | $6M | $7M | $6M | $17M | $34M | $6M | $10M | $5M | $3M | $3M | $3M | $7M | |
| Investing Cash Flow | $-8M | $-27M | $-61M | $-11M | $-29M | $-1M | $-6M | $-1M | $-3M | $-2M | $-189.0K | $-3M | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | $-219.0K | $-255.0K | · | |
| Stock Repurchased | $0 | $0 | $4M | $126M | $56M | $5M | $33M | $30M | · | · | $11M | $34M | |
| Net Stock Activity | $0 | $0 | $-4M | $-126M | $-56M | $-5M | $-33M | $-30M | · | · | $-11M | · | |
| Dividends Paid | $195.0K | $715.0K | $73M | $72M | $64M | $53M | $35M | $23M | $15M | $12M | · | · | |
| Financing Cash Flow | $-564.0K | $-2M | $-80M | $-200M | $-125M | $-57M | $-82M | $-53M | $-17M | $-13M | $-12M | $-35M | |
| Net Change in Cash | $-2M | $-4M | $7M | $-16M | $-60M | $87M | $-4M | $6M | $23M | $10M | $18M | $-12M | |
| Taxes Paid | $10M | $-2M | $34M | $37M | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $1M | $17M | $141M | $178M | $60M | $139M | $74M | $56M | $40M | $22M | $27M | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 71.3% | 73.8% | 72.4% | 71.3% | 73.9% | 74.7% | 75.2% | 75.8% | 75.5% | 74.9% | 73.8% | · | |
| Operating Margin | -3.7% | 0.48% | 11.8% | 11.6% | 14.2% | 14.3% | 12.8% | 13.8% | 13.1% | 9.8% | 10.5% | · | |
| Net Margin | -4.8% | 0.35% | 9.3% | 9.0% | 10.8% | 11.0% | 10.9% | 11.1% | 9.2% | 6.5% | 7.3% | · | |
| Pretax Margin | -1.5% | 0.63% | 12.0% | 11.5% | 14.2% | 14.4% | 12.9% | 14.1% | 13.4% | 9.9% | 10.9% | · | |
| EBITDA Margin | 0.01% | 2.6% | 13.0% | 12.2% | 14.6% | 15.1% | 13.4% | 14.7% | 14.5% | 11.8% | 13.1% | · | |
| ROA | -7.0% | 0.70% | 31.8% | 40.2% | 48.6% | 43.7% | 42.8% | 35.4% | 20.8% | 15.0% | 17.2% | · | |
| ROE | -9.0% | 1.0% | 50.4% | 94.0% | 82.3% | 69.2% | 72.1% | 50.5% | 27.1% | 19.3% | 23.7% | · | |
| ROIC | -23.7% | 0.76% | 48.4% | 93.0% | 81.1% | 65.4% | 73.3% | 50.1% | 25.1% | 18.4% | 21.3% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.7 | 3.3 | 2.4 | 1.6 | 1.8 | 2.1 | 1.9 | 2.4 | 3.4 | 4.1 | 3.7 | · | |
| Quick Ratio | 3.9 | 2.5 | 1.0 | 0.6 | 0.6 | 1.6 | 1.2 | 1.7 | 2.7 | 3.2 | 2.9 | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.4 | 2.0 | 3.4 | 4.5 | 4.5 | 4.0 | 3.9 | 3.2 | 2.3 | 2.3 | 2.3 | · | |
| Inventory Turnover | 3.5 | 3.3 | 3.4 | 3.1 | 3.4 | 4.6 | 4.0 | 4.1 | 3.9 | 4.4 | 4.9 | · | |
| Receivables Turnover | · | · | · | · | · | 925.1 | 583.1 | 467.4 | 307.2 | 181.8 | 166.2 | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $18.10 | $19.21 | $18.49 | $14.26 | $17.47 | $13.36 | $8.91 | $9.19 | $9.07 | $8.09 | $7.51 | · | |
| Revenue / Share | $35.13 | $54.95 | $98.16 | $141.77 | $129.19 | $78.89 | $58.90 | $41.48 | $24.95 | $22.98 | $22.60 | · | |
| Cash Flow / Share | $0.62 | $2.23 | $13.52 | $17.26 | $8.00 | $12.25 | $6.95 | $5.03 | $3.58 | $2.12 | $2.44 | · | |
| Cash / Share | $8.13 | $8.31 | $8.67 | $8.06 | $8.99 | $13.91 | $6.54 | $6.86 | $6.27 | $4.42 | $3.56 | · | |
| Dividend / Share | $0.00 | $0.00 | $4.95 | $6.56 | $5.68 | $4.52 | $3.38 | $2.19 | $1.44 | $1.07 | $0.25 | $0.00 | |
| EPS (TTM) | $-1.70 | $0.19 | $9.10 | $12.73 | $13.89 | $8.68 | $6.43 | $4.62 | $2.29 | $1.49 | $1.66 | $1.03 |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -36.0% | -43.8% | -32.9% | 4.8% | 63.2% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -37.7% | -26.6% | 4.7% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -16.2% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | -97.9% | -28.5% | -8.3% | 60.0% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | · | -76.1% | 1.6% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | · | -97.9% | -30.8% | -12.5% | 59.5% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | · | -76.6% | -1.1% | · | · | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | -67.4% | · | · | · | · | · | · | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $386M | $602M | $1.07B | $1.60B | $1.53B | $935M | $714M | $501M | $302M | $275M | $273M | $285M | |
| Net Income TTM | $-19M | $2M | $99M | $144M | $164M | $103M | $78M | $56M | $28M | $18M | $20M | $13M | |
| Market Cap | $117M | $193M | $732M | $1.25B | $2.43B | $2.31B | $1.29B | $1.48B | $836M | $494M | $358M | · | |
| P/E | -6.3 | 92.7 | 7.4 | 9.1 | 15.1 | 22.6 | 17.0 | 27.1 | 30.5 | 27.9 | 18.3 | 32.6 | |
| P/S | 0.3 | 0.3 | 0.7 | 0.8 | 1.6 | 2.5 | 1.8 | 3.0 | 2.8 | 1.8 | 1.3 | · | |
| P/B | 0.6 | 0.9 | 3.6 | 8.1 | 12.0 | 14.7 | 12.3 | 13.6 | 7.7 | 5.1 | 4.0 | · | |
| P / Tangible Book | 0.6 | 0.9 | 3.6 | 8.1 | 12.0 | 14.7 | · | · | · | · | · | · | |
| P / Cash Flow | 17.1 | 7.9 | 5.0 | 6.4 | 25.7 | 15.9 | 15.3 | 24.4 | 19.3 | 19.5 | 12.2 | · | |
| P / FCF | 94.0 | 11.3 | 5.2 | 7.1 | 40.2 | 16.6 | 17.4 | 26.6 | 20.9 | 22.0 | 13.5 | · | |
| Dividend Yield | 0.17% | 0.37% | 10.0% | 5.7% | 2.6% | 2.3% | 2.8% | 1.6% | 1.8% | 2.4% | · | · | |
| Earnings Yield | -15.9% | 1.1% | 13.5% | 11.0% | 6.6% | 4.4% | 5.9% | 3.7% | 3.3% | 3.6% | 5.5% | 3.1% | |
| Payout Ratio | -1.0% | 34.2% | 73.5% | 49.9% | 38.9% | 51.7% | 45.4% | 41.5% | 55.5% | 66.7% | · | · | |
| Annual Payout | $195.0K | $715.0K | $73M | $72M | $64M | $53M | $35M | $23M | $15M | $12M | · | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $76M | $76M | $75M | $89M | $106M | $116M | $119M | $140M | $169M | $175M | $191M | $236M | $296M | $349M | $337M | $390M | |
| Cost of Revenue | $23M | $24M | $23M | $27M | $29M | $31M | $31M | $34M | $45M | $47M | $50M | $58M | $85M | $103M | $104M | $108M | |
| Gross Profit | $53M | $52M | $52M | $62M | $77M | $84M | $88M | $106M | $123M | $127M | $141M | $177M | $211M | $246M | $234M | $283M | |
| SG&A Expense | $58M | $55M | $60M | $66M | $78M | $86M | $88M | $104M | $131M | $119M | $133M | $152M | $172M | $193M | $201M | $235M | |
| Operating Income | $-4M | $-3M | $-8M | $-4M | $-1M | $-1M | $708.0K | $2M | $-8M | $8M | $9M | $26M | $39M | $54M | $33M | $48M | |
| Interest Income | $1M | $1M | · | $1M | $1M | $1M | · | $1M | $1M | $1M | · | · | · | · | · | · | |
| Other Non-op | $-11.0K | $-25.0K | $-1M | $-2.0K | $3M | $487.0K | $-2M | $-2M | $-4M | $4M | $-50.0K | $7.0K | $-51.0K | $-1.0K | $-710.0K | $-17.0K | |
| Pretax Income | $-3M | $-2M | $-6M | $-3M | $3M | $526.0K | $1M | $2M | $-11M | $12M | $10M | $27M | $39M | $53M | $32M | $48M | |
| Income Tax | $109.0K | $181.0K | $12M | $-396.0K | $395.0K | $1M | $474.0K | $449.0K | $-2M | $3M | $4M | $3M | $9M | $13M | $6M | $12M | |
| Net Income | $-3M | $-2M | $-18M | $-2M | $2M | $-772.0K | $800.0K | $1M | $-8M | $8M | $6M | $23M | $30M | $40M | $27M | $36M | |
| EPS (Basic) | $-0.28 | $-0.19 | $-1.65 | $-0.21 | $0.23 | $-0.07 | $0.08 | $0.10 | $-0.75 | $0.76 | $0.55 | $2.12 | $2.78 | $3.68 | $2.46 | $3.30 | |
| EPS (Diluted) | $-0.28 | $-0.19 | $-1.64 | $-0.21 | $0.22 | $-0.07 | $0.08 | $0.10 | $-0.75 | $0.76 | $0.54 | $2.12 | $2.77 | $3.67 | $2.45 | $3.27 | |
| Shares (Basic) | 11,135,000 | 11,006,000 | · | 10,991,000 | 10,991,000 | 10,948,000 | · | 10,937,000 | 10,937,000 | 10,909,000 | · | 10,892,000 | 10,888,000 | 10,864,000 | · | 10,964,000 | |
| Shares (Diluted) | 11,135,000 | 11,006,000 | · | 10,991,000 | 11,060,000 | 10,948,000 | · | 10,971,000 | 10,937,000 | 10,958,000 | · | 10,933,000 | 10,917,000 | 10,899,000 | · | 11,042,000 | |
| EBITDA | $-4M | $188.0K | · | $-4M | $-1M | $2M | · | $2M | $-8M | $11M | · | $26M | $39M | $56M | · | $48M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $72M | $72M | $89M | $100M | $102M | $92M | $91M | $115M | $108M | $97M | · | $113M | $147M | $124M | · | $70M | |
| Short-term Investments | $98M | $97M | $78M | $74M | $61M | $73M | $71M | $55M | $55M | $59M | · | · | · | · | · | $0 | |
| Inventory | $21M | $21M | $20M | $23M | $30M | $39M | $42M | $40M | $40M | $46M | · | $58M | $69M | $97M | · | $145M | |
| Prepaid Expense | $6M | $7M | $9M | $7M | $9M | $10M | $10M | $7M | $12M | $11M | · | $8M | $13M | $10M | · | $14M | |
| Current Assets | $202M | $203M | $202M | $208M | $206M | $214M | $214M | $225M | $224M | $220M | · | $224M | $229M | $230M | · | $230M | |
| PP&E (Net) | $28M | $30M | $31M | $33M | $35M | $36M | $38M | $39M | $40M | $51M | · | $53M | $54M | $56M | · | $58M | |
| PP&E (Gross) | · | · | $99M | · | · | · | $96M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $68M | · | · | · | $58M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $6M | $7M | $8M | $7M | $8M | $9M | $10M | $11M | $12M | $14M | · | $16M | $14M | $14M | · | $13M | |
| Total Assets | $260M | $252M | $248M | $268M | $269M | $280M | $284M | $291M | $294M | $303M | · | $320M | $319M | $322M | · | $326M | |
| Accounts Payable | $36M | $38M | $38M | $41M | $40M | $52M | $56M | $66M | $69M | $71M | · | $103M | $105M | $113M | · | $148M | |
| Current Liabilities | $42M | $42M | $43M | $47M | $46M | $61M | $64M | $72M | $75M | $77M | · | $110M | $115M | $132M | · | $154M | |
| Capital Leases | $22M | $12M | $6M | $7M | $7M | $8M | $10M | $12M | $13M | $15M | · | $17M | $18M | $19M | · | $22M | |
| Total Liabilities | $64M | $54M | $49M | $54M | $53M | $69M | $74M | $84M | $88M | $92M | · | $127M | $133M | $151M | · | $176M | |
| Common Stock | $11.0K | $11.0K | $11.0K | $11.0K | $11.0K | $11.0K | $11.0K | $11.0K | $11.0K | $11.0K | · | $11.0K | $11.0K | $11.0K | · | $11.0K | |
| Paid-in Capital | $43M | $41M | $40M | $38M | $37M | $35M | $33M | $31M | $30M | $28M | · | $24M | $22M | $19M | · | $19M | |
| Retained Earnings | $153M | $156M | $158M | $176M | $178M | $176M | $177M | $176M | $175M | $183M | · | $169M | $164M | $152M | · | $132M | |
| Treasury Stock | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | · | · | |
| AOCI | $11.0K | $33.0K | $234.0K | $220.0K | $179.0K | $239.0K | $180.0K | $349.0K | $26.0K | $22.0K | · | $141.0K | $123.0K | $33.0K | · | $391.0K | |
| Stockholders' Equity | $196M | $198M | $199M | $215M | $216M | $211M | $210M | $207M | $205M | $211M | $201M | $193M | $186M | $171M | $155M | $151M | |
| Liabilities + Equity | $260M | $252M | $248M | $268M | $269M | $280M | $284M | $291M | $294M | $303M | · | $320M | $319M | $322M | · | $326M | |
| Shares Outstanding | 11,181,000 | 11,119,000 | 10,991,000 | 10,991,000 | 10,991,000 | 10,991,000 | 10,938,000 | 10,937,000 | 10,937,000 | 10,937,000 | · | 10,892,000 | 10,889,000 | 10,887,000 | · | 10,928,000 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $3M | $3M | $3M | $3M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Stock-based Comp | $2M | $2M | $2M | $910.0K | $3M | $2M | $2M | $606.0K | $2M | $2M | $2M | $3M | $3M | $606.0K | $3M | $3M | |
| Deferred Tax | · | $0 | $12M | $-648.0K | $-20.0K | $20.0K | $-8M | $106.0K | $-103.0K | $112.0K | $7M | $-6M | $0 | $800.0K | $822.0K | $-2M | |
| Other Non-cash | · | $-3M | · | · | · | $-1M | · | · | · | $-7M | · | · | · | $20M | · | · | |
| Operating Cash Flow | $2M | $260.0K | $-5M | $12M | $-3M | $3M | $-5M | $9M | $13M | $7M | $11M | $30M | $43M | $64M | $52M | $55M | |
| CapEx | $969.0K | $1M | $1M | $1M | $1M | $2M | $2M | $1M | $2M | $2M | $946.0K | $2M | $2M | $2M | $9M | $2M | |
| Investing Cash Flow | $-1M | $-17M | $-5M | $-14M | $13M | $-2M | $-19M | $-2M | $-3M | $-3M | $-11M | $-46M | $-2M | $-2M | $-9M | $-2M | |
| Stock Repurchased | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $4M | $6M | $20M | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $-4M | · | · | |
| Dividends Paid | $83.0K | $87.0K | $0 | $0 | $1.0K | $194.0K | $0 | $1.0K | $4.0K | $710.0K | $18M | $18M | $18M | $19M | $18M | $18M | |
| Financing Cash Flow | $-83.0K | $-901.0K | $1.0K | $0 | $-2.0K | $-563.0K | $-1.0K | $-3.0K | $-20.0K | $-1M | $-18M | $-18M | $-18M | $-26M | $-24M | $-45M | |
| Net Change in Cash | $381.0K | $-18M | $-10M | $-2M | $10M | $789.0K | $-24M | $7M | $11M | $3M | $-18M | $-35M | $24M | $36M | $18M | $9M | |
| Taxes Paid | · | $241.0K | · | · | · | $3M | · | · | · | $-100.0K | · | · | · | $-46.0K | $3M | $4M | |
| Free Cash Flow | · | $-836.0K | · | · | · | $2M | · | · | · | $5M | · | · | · | $62M | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 69.9% | 68.1% | · | 69.5% | 72.6% | 72.8% | · | 75.4% | 73.2% | 72.9% | · | 75.2% | 71.1% | 70.6% | · | 72.5% | |
| Operating Margin | -5.7% | -4.3% | · | -4.6% | -1.0% | -1.1% | · | 1.5% | -4.7% | 4.5% | · | 10.8% | 13.1% | 15.3% | · | 12.3% | |
| Net Margin | -4.1% | -2.8% | · | -2.5% | 2.4% | -0.67% | · | 0.81% | -4.8% | 4.8% | · | 9.8% | 10.2% | 11.5% | · | 9.3% | |
| Pretax Margin | -3.9% | -2.5% | · | -3.0% | 2.7% | 0.45% | · | 1.1% | -6.3% | 6.6% | · | 11.3% | 13.2% | 15.3% | · | 12.3% | |
| EBITDA Margin | -5.7% | 0.25% | · | -4.6% | -1.0% | 1.7% | · | 1.5% | -4.7% | 6.4% | · | 10.8% | 13.1% | 16.2% | · | 12.3% | |
| ROA | -1.2% | -0.80% | · | -0.81% | 0.88% | -0.26% | · | 0.37% | -2.7% | 2.7% | · | 7.2% | 9.2% | 10.8% | · | 10.4% | |
| ROE | -1.5% | -1.0% | · | -1.1% | 1.2% | -0.37% | · | 0.56% | -4.2% | 4.4% | · | 13.5% | 19.2% | 20.7% | · | 20.8% | |
| ROIC | -2.3% | -1.8% | · | -1.6% | -0.43% | 0.88% | · | 0.73% | -2.9% | 2.7% | · | 11.5% | 16.2% | 23.5% | · | 24.2% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.9 | 4.8 | · | 4.4 | 4.5 | 3.5 | · | 3.1 | 3.0 | 2.8 | · | 2.0 | 2.0 | 1.7 | · | 1.5 | |
| Quick Ratio | 4.1 | 4.0 | · | 3.7 | 3.5 | 2.7 | · | 2.3 | 2.2 | 2.0 | · | 1.0 | 1.3 | 0.9 | · | 0.5 |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | · | 0.3 | 0.4 | 0.4 | · | 0.5 | 0.6 | 0.6 | · | 0.7 | 0.9 | 0.9 | · | 1.1 | |
| Inventory Turnover | 0.9 | 0.8 | · | 0.9 | 0.8 | 0.7 | · | 0.7 | 0.8 | 0.7 | · | 0.6 | 0.8 | 0.7 | · | 0.8 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $17.56 | $17.78 | · | $19.53 | $19.65 | $19.19 | · | $18.96 | $18.77 | $19.29 | · | $17.72 | $17.04 | $15.70 | · | $13.77 | |
| Revenue / Share | $6.86 | $6.91 | · | $8.13 | $9.54 | $10.57 | · | $12.78 | $15.41 | $15.95 | · | $21.57 | $27.13 | $32.02 | · | $35.36 | |
| Cash Flow / Share | · | $0.02 | · | · | · | $0.31 | · | · | · | $0.66 | · | · | · | $5.88 | · | · | |
| Cash / Share | $6.43 | $6.43 | · | $9.06 | $9.25 | $8.34 | · | $10.54 | $9.88 | $8.91 | · | $10.35 | $13.54 | $11.37 | · | $6.38 | |
| Dividend / Share | · | · | · | · | · | · | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.65 | $1.65 | $1.65 | $1.64 | $1.64 | |
| EPS (TTM) | $-2.32 | $-1.82 | · | $0.02 | $0.33 | $-0.64 | · | $0.65 | $2.67 | $6.19 | · | $11.01 | $12.16 | $12.81 | · | $13.19 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $317M | $346M | · | $430M | $480M | $543M | · | $674M | $770M | $898M | · | $1.22B | $1.37B | $1.53B | · | $1.64B | |
| Net Income TTM | $-26M | $-20M | · | $247.0K | $4M | $-7M | · | $7M | $29M | $68M | · | $120M | $133M | $142M | · | $151M | |
| Market Cap | $119M | $113M | · | $150M | $154M | $148M | · | $209M | $239M | $419M | · | $815M | $1.00B | $1.13B | · | $1.18B | |
| P/E | -4.6 | -5.6 | · | 683.5 | 42.6 | -21.1 | · | 29.4 | 8.2 | 6.2 | · | 6.8 | 7.6 | 8.1 | · | 8.2 | |
| P/S | 0.4 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.5 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | |
| P/B | 0.6 | 0.6 | · | 0.7 | 0.7 | 0.7 | · | 1.0 | 1.2 | 2.0 | · | 4.2 | 5.4 | 6.6 | · | 7.9 | |
| P / Tangible Book | 0.6 | 0.6 | · | 0.7 | 0.7 | 0.7 | · | 1.0 | 1.2 | 2.0 | · | 4.2 | 5.4 | 6.6 | · | 7.9 | |
| P / Cash Flow | · | 435.8 | · | · | · | 43.5 | · | · | · | 57.6 | · | · | · | 17.6 | · | · | |
| Dividend Yield | 0.14% | 0.08% | · | 0.13% | 0.13% | 0.13% | · | 8.9% | 15.4% | 13.0% | · | 8.9% | 7.3% | 6.6% | · | 6.0% | |
| Earnings Yield | -21.9% | -17.9% | · | 0.15% | 2.4% | -4.8% | · | 3.4% | 12.2% | 16.2% | · | 14.7% | 13.2% | 12.4% | · | 12.2% | |
| Payout Ratio | · | -4.1% | · | · | · | -25.1% | · | · | · | 8.5% | · | · | · | 47.9% | · | · | |
| Annual Payout | $170.0K | $88.0K | · | $195.0K | $196.0K | $199.0K | · | $19M | $37M | $55M | · | $73M | $73M | $74M | · | $71M |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $386M | $602M | $1.07B | $1.60B | $1.53B |
| Gross Margin % | 71.3% | 73.8% | 72.4% | 71.3% | 73.9% |
| Operating Margin % | -3.7% | 0.48% | 11.8% | 11.6% | 14.2% |
| Net Income | $-19M | $2M | $99M | $144M | $164M |
| Diluted EPS | $-1.70 | $0.19 | $9.10 | $12.73 | $13.89 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 4.7 | 3.3 | 2.4 | 1.6 | 1.8 |
| Quick Ratio | 3.9 | 2.5 | 1.0 | 0.6 | 0.6 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $1M | $17M | $141M | $178M | $60M |
Institutional owners (13F) 123 filers · $106.7M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 26 (-5 vs prior Q) | 24 (+7 vs prior Q) | 47 (+12 vs prior Q) | 29 (-4 vs prior Q) | -931K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | $8,261,052 | 778,610 | 7.74% | Shares |
| VANGUARD GROUP INC | $7,598,810 | 711,499 | 7.12% | Shares |
| Steamboat Capital Partners, LLC | $7,498,076 | 706,699 | 7.03% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $5,758,047 | 542,700 | 5.40% | Call option |
| TWO SIGMA INVESTMENTS, LP | $5,107,452 | 481,381 | 4.79% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $4,738,575 | 446,614 | 4.44% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $4,212,128 | 396,996 | 3.95% | Shares |
| BlackRock, Inc. | $3,920,427 | 369,503 | 3.68% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $3,855,669 | 363,394 | 3.61% | Shares |
| AMERICAN CENTURY COMPANIES INC | $3,383,646 | 318,911 | 3.17% | Shares |
| MORGAN STANLEY | $3,103,524 | 292,508 | 2.91% | Shares |
| GOLDMAN SACHS GROUP INC | $2,579,132 | 243,085 | 2.42% | Shares |
| MARSHALL WACE, LLP | $2,563,897 | 241,649 | 2.40% | Shares |
| AQR CAPITAL MANAGEMENT LLC | $2,508,564 | 236,434 | 2.35% | Shares |
| CITADEL ADVISORS LLC | $2,476,374 | 233,400 | 2.32% | Call option |
| Peapod Lane Capital LLC | $2,361,531 | 222,576 | 2.21% | Shares |
| Lido Advisors, LLC | $2,337,779 | 220,337 | 2.19% | Shares |
| Trexquant Investment LP | $2,256,577 | 212,684 | 2.12% | Shares |
| JANE STREET GROUP, LLC | $1,749,388 | 164,881 | 1.64% | Shares |
| COMMONS CAPITAL, LLC | $1,590,609 | 149,916 | 1.49% | Shares |
| Quinn Opportunity Partners LLC | $1,348,658 | 127,112 | 1.26% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $1,285,312 | 121,071 | 1.20% | Shares |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $1,242,198 | 117,078 | 1.16% | Shares |
| RBF Capital, LLC | $1,156,490 | 109,000 | 1.08% | Shares |
| Walleye Trading LLC | $1,145,880 | 108,000 | 1.07% | Call option |
| TWO SIGMA ADVISERS, LP | $1,098,972 | 102,900 | 1.03% | Shares |
| JPMORGAN CHASE & CO | $989,878 | 92,512 | 0.93% | Shares |
| D. E. Shaw & Co., Inc. | $979,780 | 92,345 | 0.92% | Shares |
| BANK OF AMERICA CORP /DE/ | $924,323 | 87,118 | 0.87% | Shares |
| Quantinno Capital Management LP | $880,598 | 82,997 | 0.83% | Shares |
| Divisadero Street Capital Management, LP | $847,092 | 79,839 | 0.79% | Shares |
| Virtus Family Office LLC | $838,827 | 79,060 | 0.79% | Shares |
| TUDOR INVESTMENT CORP ET AL | $806,689 | 76,031 | 0.76% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $783,846 | 73,878 | 0.73% | Shares |
| FEDERATED HERMES, INC. | $738,509 | 69,605 | 0.69% | Shares |
| Empowered Funds, LLC | $701,374 | 66,105 | 0.66% | Shares |
| CITADEL ADVISORS LLC | $696,016 | 65,600 | 0.65% | Put option |
| VANGUARD FIDUCIARY TRUST CO | $672,006 | 63,337 | 0.63% | Shares |
| Atom Investors LP | $659,083 | 62,119 | 0.62% | Shares |
| CITADEL ADVISORS LLC | $597,873 | 56,350 | 0.56% | Shares |
| STATE STREET CORP | $555,105 | 52,319 | 0.52% | Shares |
| GREAT LAKES ADVISORS, LLC | $547,593 | 51,611 | 0.51% | Shares |
| UBS Group AG | $532,866 | 50,223 | 0.50% | Shares |
| Engineers Gate Manager LP | $528,686 | 49,829 | 0.50% | Shares |
| MILLENNIUM MANAGEMENT LLC | $508,283 | 47,906 | 0.48% | Shares |
| SummerHaven Investment Management, LLC | $507,529 | 47,835 | 0.48% | Shares |
| Centiva Capital, LP | $471,424 | 44,432 | 0.44% | Shares |
| Susquehanna Portfolio Strategies, LLC | $443,254 | 41,777 | 0.42% | Shares |
| Jump Financial, LLC | $429,705 | 40,500 | 0.40% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $422,278 | 39,800 | 0.40% | Put option |
Activists & 5%+ owners 8 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Parsa Kiai, Steamboat Capital Partners, LLC | Aug. 21, 2026 | 7.10% | Amendment | · | SEC |
| Steamboat Capital Partners, LLC, Parsa Kiai | March 20, 2026 | 6.00% | Initial filing | Board campaign | SEC |
| Engaged Capital Flagship Master Fund, LP, Engaged Capital Co-Invest X, LP, Engaged Capital Co-Invest X-A, LP, Engaged Capital Opportunities Fund, LP, Engaged Capital Flagship Fund, LP, Engaged Capital Flagship Fund, Ltd., Engaged Capital, LLC, Engaged Capital Holdings, LLC, Glenn W. Welling ×5 filings | July 15, 2020 | · | Initial filing | · | SEC |
| Engaged Capital Master Feeder II, LP, Engaged Capital Master Feeder I, LP, Engaged Capital I, LP, Engaged Capital I Offshore, Ltd., Engaged Capital II, LP, Engaged Capital II Offshore Ltd., Engaged Capital, LLC, Engaged Capital Holdings, LLC, Glenn W. Welling | June 3, 2016 | · | Initial filing | · | SEC |
| ModusLink Securities Corp., ModusLink Global Solutions, Inc. ×6 filings | Jan. 19, 2016 | · | Initial filing | · | SEC |
| Engaged Capital Master Feeder I, LP, Engaged Capital Master Feeder II, LP, Engaged Capital I, LP, Engaged Capital I Offshore, Ltd., Engaged Capital II, LP, Engaged Capital II Offshore Ltd., Engaged Capital, LLC, Engaged Capital Holdings, LLC, Glenn W. Welling ×4 filings | Sept. 1, 2015 | · | Initial filing | · | SEC |
| Undisclosed reporting person, Undisclosed reporting person | Dec. 12, 2002 | · | Initial filing | · | SEC |
| Undisclosed reporting person, Undisclosed reporting person | May 6, 2002 | · | Initial filing | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 52 insiders · 20 officers · 28 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Michael S Mcdevitt | Chief Executive Officer | Jan. 5, 2011 S | 340,012 | 0 | 0 | $0 |
| James P. Maloney | Chief Financial Officer | March 25, 2026 A | 73,033 | 0 | 0 | $0 |
| Timothy G Robinson | Chief Financial Officer | Feb. 20, 2020 F | 47,214 | 0 | 0 | $0 |
| Connors Brendan | Chief Financial Officer | Jan. 5, 2011 S | 91,484 | 0 | 0 | $0 |
| Mehrnaz Mona Ameli | President, OPTAVIA | Nov. 17, 2017 F | 10,809 | 0 | 0 | $0 |
| Margaret Macdonald Sheetz | President & COO | April 1, 2016 S | 327,346 | 0 | 0 | $0 |
| Jonathan Barrett Mackenzie | VP, Finance & CAO | March 25, 2026 A | 20,838 | 0 | 0 | $0 |
| Stephen Kyle Johnson | VP, Finance & CAO | March 17, 2021 A | 665 | 0 | 0 | $0 |
| Joseph P Kelleman | Vice President of Finance | Feb. 20, 2019 A | 2,355 | 0 | 0 | $0 |
| Jason L Groves | Executive VP & General Counsel | Feb. 17, 2015 A | 21,697 | 0 | 0 | $0 |
| Jeanette M. Mills | Executive Vice President | Aug. 18, 2014 S | 20,116 | 0 | 0 | $0 |
| Guy Sheetz | Executive Vice President | Feb. 5, 2014 A | 410,430 | 0 | 0 | $0 |
| Dominick Vietri | Executive Vice President | Feb. 5, 2014 A | 3,804 | 0 | 0 | $0 |
| Brian Lloyd | Executive Vice President | Feb. 5, 2014 A | 1,865 | 0 | 0 | $0 |
| Donald Gould | Executive Vice President | Feb. 5, 2014 A | 6,804 | 0 | 0 | $0 |
| Brian Kagen | Executive Vice President | Feb. 5, 2014 A | 3,804 | 0 | 0 | $0 |
| Jeanne M Uphouse | Executive Vice President | Feb. 5, 2014 A | 3,804 | 0 | 0 | $0 |
| Brazdley T Macdonald | Exec. Chairman of the Board | Jan. 5, 2011 S | 579,521 | 0 | 0 | $0 |
| Leo Williams | Executive Vice President | Nov. 29, 2010 S | 15,000 | 0 | 0 | $0 |
| Robert J Hallock | Corporate Vice President | Nov. 18, 2003 P | 1,000 | 0 | 0 | $0 |
| Daniel R Chard | Director | Sept. 29, 2026 S | 130,609 | 1 | 2 | $-47,575 |
| Parsa Kiai | Director | Aug. 26, 2026 P | 20,270 | 8 | 0 | $1,423,577 |
| Jeffrey Matthew Rose | Director | May 26, 2026 A | 18,419 | 0 | 0 | $0 |
| Elizabeth A. Geary | Director | May 26, 2026 A | 31,225 | 0 | 0 | $0 |
| Andrea B Thomas | Director | May 26, 2026 A | 35,697 | 0 | 0 | $0 |
| Ming Xian | Director | May 26, 2026 A | · | 0 | 0 | $0 |
| Scott Schlackman | Director | May 26, 2026 A | 42,229 | 2 | 0 | $62,950 |
| Michael A. Hoer | Director | June 25, 2025 A | 26,139 | 0 | 0 | $0 |
| Jeffrey J Brown | Director | June 25, 2025 A | 38,578 | 0 | 0 | $0 |
| Kevin G Byrnes | Director | Nov. 11, 2021 M | 14,922 | 0 | 0 | $0 |
| Michael C Macdonald | Director | Oct. 1, 2020 S | 266,179 | 0 | 0 | $0 |
| Carl E Sassano | Director | July 17, 2020 G | 18,199 | 0 | 0 | $0 |
| Charles P Connolly | Director | March 9, 2018 M | 41,374 | 0 | 0 | $0 |
| Welling Glenn W. | Director | Dec. 1, 2017 S | 22,380 | 0 | 0 | $0 |
| Jorgene K. Hartwig | Director | March 13, 2017 M | 9,808 | 0 | 0 | $0 |
| Barry B Bondroff | Director | June 11, 2015 S | 14,533 | 0 | 0 | $0 |
| John P Mcdaniel | Director | June 4, 2015 S | 18,289 | 0 | 0 | $0 |
| Jerry D Reece | Director | Feb. 17, 2015 A | 8,792 | 0 | 0 | $0 |
| Harvey C Barnum JR | Director | Feb. 17, 2015 A | 8,742 | 0 | 0 | $0 |
| Catherine T Maguire | Director | Feb. 17, 2015 A | 15,074 | 0 | 0 | $0 |
| Donald F Reilly | Director | Feb. 17, 2015 A | 0 | 0 | 0 | $0 |
| George Lavin | Director | July 31, 2013 D | 24,785 | 0 | 0 | $0 |
| Joseph D Calderone | Director | March 24, 2009 A | 21,700 | 0 | 0 | $0 |
| Carthy Dennis Mc | Director | March 24, 2009 A | 17,075 | 0 | 0 | $0 |
| Michael J Mcdevitt | Director | Feb. 15, 2007 A | 17,400 | 0 | 0 | $0 |
| VISIUM BALANCED MASTER FUND, LTD. | 10% owner | May 31, 2016 S | 0 | 0 | 0 | $0 |
| Constance J. Hallquist | · | Oct. 6, 2023 S | 2,152 | 0 | 0 | $0 |
| Shirley Macdonald | · | May 12, 2010 S | 0 | 0 | 0 | $0 |
| Mary T Travis | · | Dec. 17, 2009 S | 12,583 | 0 | 0 | $0 |
| Richard J Law | · | Aug. 13, 2009 S | 62,081 | 0 | 0 | $0 |
| RNI-NV Limited Partnership | · | Aug. 8, 2005 S | 1,088,830 | 0 | 0 | $0 |
| Scott Zion | · | July 28, 2004 P | 185,000 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 18 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| VRIG · Invesco Actively Managed Exchange-T… | 0.27% | 5,000,000 | Sept. 30, 2026 | Daily |
| IWC · iShares Trust | 0.03% | 36,261 SH | Sept. 11, 2026 | Daily |
| VSS · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.01% | 16,856 SH | Aug. 19, 2026 | Daily |
| DFSV · Dimensional ETF Trust | 0.01% | 60,623 NS | July 31, 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.00% | 2,012 NS | July 31, 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.00% | 37,570 NS | July 31, 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.00% | 5,427 SH | Sept. 30, 2026 | Daily |
| DCOR · Dimensional ETF Trust | 0.00% | 2,019 NS | July 31, 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.00% | 2,079 NS | July 31, 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.00% | 5,600 NS | July 31, 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 115,543 SH | Aug. 19, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 318,980 SH | Aug. 19, 2026 | Daily |
| VXUS · VANGUARD STAR FUNDS | 0.00% | 64,351 SH | Aug. 19, 2026 | Daily |
| VGK · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.00% | 9,806 SH | Aug. 19, 2026 | Daily |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.00% | 3,076 SH | Aug. 19, 2026 | Daily |
| VEA · VANGUARD TAX-MANAGED FUNDS | 0.00% | 42,929 SH | Aug. 19, 2026 | Daily |
| VSGX · VANGUARD WORLD FUND | 0.00% | 1,003 SH | Aug. 19, 2026 | Daily |
| SMLF · iShares Trust | · | 123,005 SH | Sept. 11, 2026 | Daily |
MED Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
12-Month Price Target
1 analysts · 2026-09-27Mean target $12.00 +2.3%
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| MED | $117M | -6.3 | -36.0% | -4.8% | -9.0% | 71.3% |
| USNA | $355M | 33.5 | 8.3% | 1.2% | 2.0% | 78.3% |
| NUS | · | 3.0 | -14.3% | 10.8% | 22.0% | 69.5% |
| NATR | $378M | 20.4 | 5.7% | 4.1% | 12.0% | 72.4% |
| NAGE | $507M | 31.8 | 29.9% | 13.4% | 24.7% | 64.3% |
| UPXI | $62M | -0.2 | 58.1% | -984.3% | 9654.9% | 89.5% |
| FTLF | · | 25.8 | 26.4% | · | · | · |
| SKIN | $177M | -8.7 | -10.0% | -3.2% | -14.1% | 65.3% |
| LFVN | $78M | 15.6 | -20.1% | 2.8% | 15.2% | 77.6% |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.